ArticleJournal of multimorbidity and comorbidity
Associations of chronic disease and multimorbidity with healthcare utilization, mortality and adverse events in Estonia.
Article in Journal of multimorbidity and comorbidity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multimorbidity is widespread, influencing disease progression and patient outcomes. Understanding the impact on the use of healthcare resources and healthcare associated harm is crucial for population-level interventions to reduce disease burden and improve quality of life. Methods: This retrospective study used administrative and clinical registry data from a 30% sample of the adult Estonian population. Multimorbidity was defined as ≥2 chronic diseases. Prevalence of chronic disease and multimorbidity was estimated among adults on January 1, 2024 (n = 324,942). Healthcare utilization included inpatient, outpatient, emergency visits, and prescription counts. Survival was assessed over five years following entry into multimorbidity strata (0-1, 2-4, 5-9, ≥10 conditions) in 2012-2024. We estimated 5-year risk of healthcare-associated harm diagnoses comparing patients with and without multimorbidity. Results: Chronic disease affected 60.3% of adults and multimorbidity 42.0%, increasing steeply with age. Multimorbidity was strongly associated with mortality, with adjusted hazard ratios of 1.61 (95% CI 1.57-1.66) for 2-4 conditions, 2.43 (2.36-2.51) for 5-9, and 3.35 (3.22-3.48) for ≥10 conditions compared with ≤1 condition. Healthcare utilization increased approximately linearly with each additional chronic disease, with 0.025 more inpatient visits, 0.034 emergency visits, 1.49 outpatient visits, and 4.04 prescriptions per person-year. Multimorbidity was also associated with higher risk of healthcare-associated adverse events, with up to sevenfold higher hazards for several complications, particularly related to procedural/surgical and prosthesis-related complications, including infections. Conclusion: Multimorbidity is prevalent in the Estonian population, increases mortality and healthcare use, and may increase healthcare-associated harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.